TickerFactsScreenerDevelopers

Atea Pharmaceuticals, Inc. (AVIR) — Operating Income

Annual figures by fiscal year, from SEC filings.

2018: -$9.48M2019: -$14.61M2020: -$11.03M2021: $138.38M2022: -$130.65M2023: -$164.16M2024: -$192.95M2025: -$180.89M-$180.89M
2018Operating Income (USD)2025
Fiscal YearOperating IncomeChange YoY
2025-$180.89M+6.3%
2024-$192.95M-17.5%
2023-$164.16M-25.7%
2022-$130.65M-194.4%
2021$138.38M+1354.6%
2020-$11.03M+24.5%
2019-$14.61M-54.1%
2018-$9.48M—